EP4157335A2 Peptide Cocktail by Hubro Therapeutics AS
Summary
The European Patent Office published application EP4157335A2 filed by Hubro Therapeutics AS (Norway) for a peptide cocktail composition, with inventors Henrik Eriksen and Jon Amund Eriksen. The application was published April 15, 2026, under IPC classifications A61K 39/00 (immunological preparations), A61P 35/00 (antineoplastic agents), and C07K 14/00 (peptides), covering designated contracting states including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, and TR.
About this source
GovPing monitors EPO Patent Bulletin - Peptides (C07K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 22 changes logged to date.
What changed
The EPO published European patent application EP4157335A2 for a peptide cocktail composition filed by Hubro Therapeutics AS, with inventors Henrik Eriksen and Jon Amund Eriksen. The application covers immunological preparations for cancer treatment as indicated by IPC classifications A61K 39/00, A61P 35/00, and C07K 14/00.
Affected parties in the pharmaceutical and biotechnology sectors should monitor this publication for potential freedom-to-operate implications in the immunotherapy and cancer treatment space, particularly in European markets where the application designates AT, BE, DE, DK, ES, FI, FR, GB, IT, NL, NO, SE, and other contracting states.
Archived snapshot
Apr 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
A PEPTIDE COCKTAIL
Publication EP4157335A2 Kind: A2 Apr 15, 2026
Applicants
Hubro Therapeutics AS
Inventors
ERIKSEN, Henrik, ERIKSEN, Jon Amund
IPC Classifications
A61K 39/00 20060101AFI20221012BHEP A61P 35/00 20060101ALI20221012BHEP C07K 14/00 20060101ALI20221012BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.